Active · per the CBE, 17 September 2026

Aveo IMMO

BE0737406173

Rechtspersoon Private limited company 1 establishment

Steenweg op Turnhout 96, 2360 Oud-Turnhout

Behind the company: Van Looveren RX radiologie BV BV, Parx BV, Dr. Ooms Erwin BV, Larx BV+1.

Active for

6 year, 10 months

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

  • Tight liquidity NBB

    Cash and receivables cover 20 % of short-term debt in 2025; threshold 65 %.

  • Not on Peppol Peppol

    Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

Aveo IMMO from Oud-Turnhout, company number BE0737406173, closed financial year 2025 with a result of € 13,001 after tax. For that financial year Aveo IMMO recorded a gross margin of € 34,370 and equity of € 98,875. Compared with financial year 2024, the result moved from € 14,465 to € 13,001. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 24, 2026.

What it is worth Growing

€ 98,875

▲ 15% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 13,001

▼ 10% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 4,120

▼ 68% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 48,875.

People and assets in 2025

Full-time equivalents

0

Average over the fiscal year, from the social balance sheet.

Debts at end 2025

Bank debt ≈ 10 years to go

€ 259,155

▼ 9% vs 2024

€ 25,303 is repaid this year. At this pace the long-term loan is gone in ≈ 10 years.

Owed to suppliers

€ 680

▼ 2% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
2022202320242025Change 2024 → 2025
Gross margin € 29,291 € 33,390 € 35,057 € 34,370 ▼ 2%
Profit after taxes € 10,016 € 12,701 € 14,465 € 13,001 ▼ 10%
Equity € 58,708 € 71,409 € 85,874 € 98,875 ▲ 15%
Total debts € 388,542 € 364,266 € 335,988 € 310,660 ▼ 8%
Cash € 1,242 € 1,312 € 12,835 € 4,120 ▼ 68%
Land & buildings € 445,775 € 434,111 € 405,349 € 394,160 ▼ 3%
Retained profit € 8,708 € 21,409 € 35,874 € 48,875 ▲ 36%
Bank debt € 333,976 € 309,213 € 284,277 € 259,155 ▼ 9%
Balance sheet total € 447,250 € 435,675 € 421,862 € 409,535 ▼ 3%

Key figures of Aveo IMMO, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Aveo IMMO?

What happened at Aveo IMMO in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 13,001 (▼ 10% vs 2024). Source: NBB ↗
  • New establishment in Oud-Turnhout. KBO
  • Start of the company according to the CBE. KBO
  • Van Looveren RX radiologie BV BV became a director. NBB
  • Parx BV became a director. NBB
  • Dr. Ooms Erwin BV became a director. NBB
  • Larx BV became a director. NBB
  • Eyselbergs BV became a director. NBB

In short

From € 10,016 profit in 2022 to € 13,001 profit in 2025.

Paid € 16,352 in corporate taxes since 2022.

Best year ever: 2024, with € 14,465 profit.

Management

The stake of DR. OOMS ERWIN, PARX, Van Looveren RX, radiologie BV, LARX, Eyselbergs comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Aveo IMMO

Behind Aveo IMMO are Van Looveren RX radiologie BV BV, Parx BV, Dr. Ooms Erwin BV, Larx BV and Eyselbergs BV. The shares are held by DR. OOMS ERWIN (20%), PARX (20%), Van Looveren RX, radiologie BV (20%), LARX (20%) and Eyselbergs (20%).

See the full network in the app

Directors

According to the 2025 annual accounts

Van Looveren RX radiologie BV BV

Director · represented by Kevin Van Looveren

Also active at: AVEO Radiologie

since 2019

Parx BV

Director · represented by Philip Ardies

Also active at: AVEO Radiologie

since 2019

Dr. Ooms Erwin BV

Managing director · represented by Erwin Ooms

Also active at: AVEO Radiologie

since 2019

Larx BV

Director · represented by Lenz Ardies

Also active at: AVEO Radiologie

since 2019

Eyselbergs BV

Director · represented by Michiel Paul Eyselbergs

Also active at: AVEO Radiologie

since 2019

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Steenweg op Turnhout 96

2360 Oud-Turnhout

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0737.406.173
VAT number
BE 0737.406.173
Registered office
Steenweg op Turnhout 96, 2360 Oud-Turnhout
Names & denominations
Aveo IMMO
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
5 November 2019
Peppol
Not registered

Frequently asked questions

What is the address of Aveo IMMO?
The registered office of Aveo IMMO is located at Steenweg op Turnhout 96, 2360 Oud-Turnhout.
Is Aveo IMMO still active?
Yes. According to the CBE (17 September 2026) Aveo IMMO is active, legal situation “Normale toestand”, started on 5 November 2019.
Is Aveo IMMO registered on Peppol?
No, Aveo IMMO is currently not registered on the Peppol network.
What is the enterprise number of Aveo IMMO?
The enterprise number of Aveo IMMO is BE0737406173.
When was Aveo IMMO founded?
Aveo IMMO was founded on 5 November 2019.
Who owns Aveo IMMO?
Behind Aveo IMMO are Van Looveren RX radiologie BV BV, Parx BV, Dr. Ooms Erwin BV, Larx BV and Eyselbergs BV. The shares are held by DR. OOMS ERWIN (20%), PARX (20%), Van Looveren RX, radiologie BV (20%), LARX (20%) and Eyselbergs (20%).